Appeal Your Insurance Denial Using AI + Q&A | Nancy Wei, MD, Lauren Rhodes, & Mark Moyad, MD MPH @ThePCRI
Appeal Your Insurance Denial Using AI + Q&A | Nancy Wei, MD, Lauren Rhodes, & Mark Moyad, MD MPH  @ThePCRI
Uploaded August 2025 | Updated September 2026, 2 weeks ago
Donate to PCRI: pcri.org/donate
For more information, visit pcri.org

00:02 Introduction: Addressing insurance denials in prostate cancer care.
00:20 Goal: Empowering patients with appeal-writing tools.
01:02 AI chatbots as appeal support tools.
01:30 Agenda: Chatbots, denial letters, and drafting appeals.
02:43 What AI chatbots are and how they help.
03:54 How chatbots learn and improve.
05:42 Free chatbot options for appeals.
07:04 ChatGPT strengths and limitations.
09:55 Google Gemini pros and cons.
10:20 Claude Bionthropic features and limits.
12:39 Privacy concerns with AI use.
14:15 Importance of understanding denial letters.
16:10 Reading and analyzing denial letters.
18:02 Common denial reasons.
20:51 Example denial letters and appeal rights.
23:09 Preparing medical history for appeals.
24:18 Using imaging reports in appeals.
24:47 Strengthening appeals with peer-reviewed research.
25:01 Referencing medical guidelines.
25:55 Organizing records for efficiency.
26:39 Converting information into appeal letters with AI.
27:34 Giving AI detailed context.
28:15 Maintaining professional tone and format.
29:10 Crafting clear prompts for AI.
32:13 Revising appeals with added information.
35:01 Adding clinical citations to appeals.
37:04 Using template letters to protect privacy.
41:12 Reviewing letters before submission.
43:08 AI as a supportive—not replacement—tool.
44:04 Options to appeal after denial.
48:56 Dr. Quan’s guitar skills.
49:10 Music talent vs. patient care focus.
50:34 Australian sports chant: “Aussie Aussie Aussie.”
51:04 Vegemite as a popular Australian food.
56:07 Low appeal rates for denied claims.
01:00:15 Free AI services for appeals.
01:01:41 ChatGPT recommended for ease of use.
01:02:35 Saved AI conversations for reference.
01:06:39 Line-by-line review of denial letters.
01:08:17 Identifying key denial reasons.
01:09:24 Choosing between personal or template letters.
01:10:35 Template letters to protect privacy.
01:11:30 Mayo team’s patient empowerment mission.
01:12:50 Importance of clear AI prompts.
01:16:30 Resolving simple coding errors by phone.
01:17:12 Value of NCCN guidelines in appeals.
01:19:00 Two types of insurance appeals.
01:20:51 Role of peer-to-peer reviews.
01:21:05 Assertiveness in appeals: “The squeaky wheel wins.”
01:27:43 Success rates for active patient appeals.
01:30:25 Lunch at Outback Steakhouse.
01:31:07 Sharing fun meal experiences.
01:32:30 AI collaboration for successful appeals.
01:33:12 Reducing administrative burdens.
01:34:08 Supporting patients against healthcare stress.

Don't know your stage? Take the quiz: visit prostatecancerstaging.org

To learn more about prostate cancer, visit pcri.org

Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
Appeal Your Insurance Denial Using AI + Q&A | Nancy Wei, MD, Lauren Rhodes, & Mark Moyad, MD MPHImaging Negative Cancers | 2026 Mid-Year Update | Eugene Kwon, MD + Mark Moyad, MD Q&A #PCRI#Brachytherapy For #ProstateCancer: Clinical Trials Results  | #MarkScholzMD #PCRICastration Resistant #ProstateCancer | #MarkScholzMD #PCRIHeart, Lung, Colon, & Glaucoma Screening | #MarkScholzMD #AlexScholz #PCRI #MensHealthDo You Really Need #ProstateCancer Treatment Right Away? | #MarkScholzMD #AlexScholz #PCRIA Discussion on Nutrition & #ProstateCancer With Nutrition Expert Verne Varona & #AlexScholzPSA Bounce With #ProstateCancer Radiation #MarkScholzMD #PCRIIncontinence & Side Effects #ProstateCancer Radiation & Surgery Jeffrey Brady, MD & Mark Moyad, MDPSA Tests For #ProstateCancer | #MarkScholzMD #PCRIPathology & Relapsed Prostate Cancer | 2026 #PCRI Mid-Year Update #MarkScholzMD #MarkMoyadMDRadiation & Side Effects For Prostate Cancer | Mack Roach III, MD & Q+A with Mark Moyad, MD #PCRI
Prostate Cancer Research Institute |

Appeal Your Insurance Denial Using AI + Q&A | Nancy Wei, MD, Lauren Rhodes, & Mark Moyad, MD MPH

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER